STOCK MARKET BSE NSE

Hospitals 'profiteering' by selling Remdesivir at printed rate: Uddhav government

The Food and Drugs Administration (FDA) has now proposed to the Center that the printed retail price on the injection be lowered to avoid patients getting overcharged.

Published: 12th March 2021 12:00 PM  |   Last Updated: 12th March 2021 12:00 PM   |  A+A-

A vial of the investigational drug remdesivir is visually inspected at a Gilead Sciences manufacturing site in US

A vial of the investigational drug remdesivir is visually inspected at a Gilead Sciences manufacturing site in US. (File photo| AP)

By PTI

MUMBAI: Several hospitals in Maharashtra have been recovering the printed price of Remdesivir injections, used for COVID-19 treatment, from the patients and making profit, officials said on Thursday.

The Food and Drugs Administration (FDA) has now proposed to the Center that the printed retail price on the injection be lowered to avoid patients getting overcharged.

The FDA and Medical Education and Drugs departments held joint meetings in this regard last week, an official statement said.

It came to light that hospitals are recovering the printed price or MRP from patients.

"Since February this year, the printed price on the 100 mg Remdesivir was not reduced though the actual selling price by wholesalers to hospitals was brought down by the state government.

"However, most of the hospitals were found quoting the printed price to the patients which was 10 to 30 per cent higher (than the procurement cost)," it said.

Hospitals were thus found to be "profiteering", the government said.

The departments proposed that private hospitals be allowed to charge up to 30 per cent more over the printed price on the 100 mg Remdesivir injection.

The FDA accepted the proposal and the final price will be decided soon, it said.

At the same time, the printed price will be kept minimum so that it would not put burden on patients, it added.

The FDA has sent a proposal to the Center, asking it to keep the retail price lower under the Drugs Price Control Order 2013, the state government said.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp